Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Marimed (MRMD) Debt to Equity (2016 - 2023)

Marimed has reported Debt to Equity over the past 12 years, most recently at $0.28 for Q3 2023.

  • Quarterly Debt to Equity changed N/A to $0.28 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $0.28 through Sep 2023, changed N/A year-over-year, with the annual reading at $0.48 for FY2021, 67.47% down from the prior year.
  • Debt to Equity was $0.28 for Q3 2023 at Marimed, down from $0.3 in the prior quarter.
  • Over five years, Debt to Equity peaked at $153.66 in Q3 2020 and troughed at -$2.84 in Q2 2020.
  • The 5-year median for Debt to Equity is $0.15 (2021), against an average of $9.59.
  • The largest YoY upside for Debt to Equity was 3060128.43% in 2020 against a maximum downside of 304992.6% in 2020.
  • A 5-year view of Debt to Equity shows it stood at $0.28 in 2019, then skyrocketed by 427.16% to $1.46 in 2020, then tumbled by 67.47% to $0.48 in 2021, then crashed by 99.78% to $0.0 in 2022, then skyrocketed by 26589.78% to $0.28 in 2023.
  • Per Business Quant, the three most recent readings for MRMD's Debt to Equity are $0.28 (Q3 2023), $0.3 (Q2 2023), and $0.37 (Q1 2023).